Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
CBIO
CBIO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CBIO News
Crescent Biopharma Grants Stock Options to Employees
4d ago
Newsfilter
Crescent Biopharma Partners with Kelun-Biotech to Expand Oncology Pipeline
Feb 26 2026
Newsfilter
Crescent Biopharma Grants Stock Options to Employees
Feb 19 2026
Newsfilter
Crescent Biopharma Launches CR-001 Clinical Trial for Solid Tumors
Feb 18 2026
Newsfilter
Crescent Biopharma to Participate in Biotech Summit 2026
Feb 05 2026
Newsfilter
Analysts Bullish on Century Communities, Target Price Set at $92
Jan 21 2026
Benzinga
Crescent Biopharma Grants 129,626 Stock Options to Attract Talent
Dec 18 2025
Globenewswire
Crescent Biopharma Unveils Inducement Award Grants
Dec 18 2025
Yahoo Finance
What’s Going On With Crescent Biopharma Stock Today?
Dec 04 2025
Benzinga
Crescent and Kelun-Biotech Finalize Oncology Partnership; Crescent Plans to Raise $185 Million; Stock Price Increases
Dec 04 2025
NASDAQ.COM
Crescent Biopharma Unveils Inducement Award Grants
Nov 17 2025
Newsfilter
HC Wainwright & Co. Affirms Buy Rating for Crescent Biopharma, Keeps $25 Price Target Intact
Aug 27 2025
Benzinga
Devon Energy Analyst Starts Coverage Optimistically; Check Out the Top 5 Initiations for Monday
Aug 25 2025
Benzinga
Crescent Biopharma Reports Second Quarter 2025 Financial Results and Recent Business Highlights
Jul 31 2025
Newsfilter
Wedbush Initiates Coverage On Crescent Biopharma with Outperform Rating, Announces Price Target of $27
Jul 14 2025
Benzinga
Altimmune, Bit Digital, Kratos Defense & Security Solutions And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Jun 26 2025
Benzinga
Show More News
